Category: Press Release - Page 64 - Psychedelic Alpha

Read more about the article GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

Post published:May 18, 2022
Post category:Press Release

Read more about the article Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference

Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference

Post published:May 13, 2022
Post category:Press Release

Read more about the article Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Post published:May 2, 2022
Post category:Press Release

Read more about the article MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022

Post published:April 26, 2022
Post category:Press Release

Read more about the article MYND Life Sciences Announces $3.5 Million Share Offering

MYND Life Sciences Announces $3.5 Million Share Offering

Post published:April 21, 2022
Post category:Press Release

Read more about the article Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Post published:April 21, 2022
Post category:Press Release

Read more about the article COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers

COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers

Post published:April 20, 2022
Post category:Press Release

Read more about the article Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT and 5-MeO-DMT Drug Candidate Compounds

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT and 5-MeO-DMT Drug Candidate Compounds

Post published:April 19, 2022
Post category:Press Release

Read more about the article Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural Psilocybin Products

Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural Psilocybin Products

Post published:April 19, 2022
Post category:Press Release

Read more about the article MindMed Collaborator Dr. Matthias Liechti to Present Topline Clinical Trial Results for LSD in Anxiety Disorders at PSYCH Symposium

MindMed Collaborator Dr. Matthias Liechti to Present Topline Clinical Trial Results for LSD in Anxiety Disorders at PSYCH Symposium

Post published:April 14, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.